KESIMPTA
NDC 0078-1007, ofatumumab, injection, solution, from Novartis Pharmaceuticals Corporation.
- Product NDC
- 0078-1007
- Status
- Listed
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125326
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0078-1007 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OFATUMUMAB20 mg/.4mL
Pharmacologic classes
CD20-directed Antibody Interactions [MoA]; CD20-directed Cytolytic Antibody [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0078-1007-68 | 00078100768 | 1 SYRINGE, GLASS in 1 CARTON (0078-1007-68) / .4 mL in 1 SYRINGE, GLASS |
| 0078-1007-98 | 00078100798 | 1 SYRINGE, GLASS in 1 CARTON (0078-1007-98) / .4 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6a8a3f53-2062-48ff-9dbe-b939df133ca3NADAC price for package 00078100768
GET /v1/drugs/nadac/00078100768
Use it
Look up 0078-1007 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0078-1007 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0078-1007. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.